Miranda Toledano
Chief Executive Officer at ENTERA BIO LTD.
Net worth: 345 518 $ as of 2024-04-29
Miranda Toledano active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ENTERA BIO LTD. | Director/Board Member | 2018-09-26 | - |
| Chief Executive Officer | 2022-07-14 | - | |
| Director of Finance/CFO | 2022-05-15 | 2022-07-14 | |
| Independent Dir/Board Member | 2018-09-26 | 2022-05-15 | |
| JOURNEY MEDICAL CORPORATION | Director/Board Member | 2021-04-30 | - |
| Independent Dir/Board Member | 2021-04-30 | - | |
Lipomedix Pharmaceuticals Ltd.
 Lipomedix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Lipomedix Pharmaceuticals Ltd. engages in the development of cancer therapy based on liposome delivery. It offers Promitil®, a proprietary formulation of a lipid-based pro-drug of MMC (MLP) which enables efficient delivery and release of active MMC to tumors in vivo. The company was founded by Alberto Gabizon and Rami Kremien and is headquartered in Jerusalem, Israel. | Director/Board Member | 2019-08-04 | - |
Career history of Miranda Toledano
Former positions of Miranda Toledano
| Companies | Position | Start | End |
|---|---|---|---|
| NEXGEL, INC. | Director/Board Member | 2021-09-08 | 2024-03-30 |
| Independent Dir/Board Member | 2021-09-08 | 2024-03-30 | |
| COMPASS THERAPEUTICS, INC. | Director/Board Member | 2021-06-24 | 2022-05-23 |
| Independent Dir/Board Member | 2021-06-24 | 2022-05-23 | |
TRIGR Therapeutics, Inc.
 TRIGR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trigr Therapeutics, Inc. engages in pharmaceuticals industry group. The company is headquartered in Irvine, CA. | Director/Board Member | 2017-12-31 | 2021-05-31 |
| Chief Operating Officer | 2017-12-31 | 2021-05-31 | |
| Director of Finance/CFO | 2017-12-31 | 2021-05-31 | |
| SORRENTO THERAPEUTICS, INC. | Corporate Officer/Principal | 2016-09-12 | 2017-07-31 |
MLV & Co. LLC
 MLV & Co. LLC Investment Banks/BrokersFinance Founded in 2010, MLV & Co. LLC is a broker/dealer located in New York City. The firm is a direct subsidiary of FBR Capital Markets Holdings, Inc. and their ultimate parent is FBR & Co. (NASDAQ: FBRC), which acquired the firm in 2015. Their research focuses on small to mid-sized companies with disruptive technologies that have the potential to drive significant market changes. MLV & Co.'s coverage universe includes the life sciences, oil & gas and metals & mining sectors. | Corporate Officer/Principal | 2011-12-31 | 2016-08-31 |
| ROYALTY PHARMA PLC | Chief Investment Officer | 2003-12-31 | 2009-12-31 |
| ░░░░░ ░ ░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Miranda Toledano
| Tufts University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Statistics
International
| United States | 10 |
| Israel | 4 |
| 2 |
Operational
| Director/Board Member | 6 |
| Corporate Officer/Principal | 4 |
| Independent Dir/Board Member | 4 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 5 |
|---|---|
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| NEXGEL, INC. | Process Industries |
| ENTERA BIO LTD. | Health Technology |
| ROYALTY PHARMA PLC | Health Technology |
| COMPASS THERAPEUTICS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Ernst & Young (Israel) Ltd.
 Ernst & Young (Israel) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young (Israel) Ltd. is an Israeli company that provides accounting services. The company is based in Tel Aviv, Israel. | Commercial Services |
RP Management LLC
 RP Management LLC Miscellaneous Commercial ServicesCommercial Services RP Management LLC provides pharmaceutical royalty liquidity services. It provides liquidity to holders of interests in revenue-producing intellectual property in biopharmaceutical products and finances the clinical development of biopharmaceutical products in exchange for a royalty interest. The firm serves research institutions, inventors, and biotechnology and pharmaceutical companies. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY. | Commercial Services |
Lipomedix Pharmaceuticals Ltd.
Lipomedix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Lipomedix Pharmaceuticals Ltd. engages in the development of cancer therapy based on liposome delivery. It offers Promitil®, a proprietary formulation of a lipid-based pro-drug of MMC (MLP) which enables efficient delivery and release of active MMC to tumors in vivo. The company was founded by Alberto Gabizon and Rami Kremien and is headquartered in Jerusalem, Israel. | Health Technology |
| Journey Medical Corp. | |
TRIGR Therapeutics, Inc.
TRIGR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trigr Therapeutics, Inc. engages in pharmaceuticals industry group. The company is headquartered in Irvine, CA. | Health Technology |
MLV & Co. LLC
MLV & Co. LLC Investment Banks/BrokersFinance Founded in 2010, MLV & Co. LLC is a broker/dealer located in New York City. The firm is a direct subsidiary of FBR Capital Markets Holdings, Inc. and their ultimate parent is FBR & Co. (NASDAQ: FBRC), which acquired the firm in 2015. Their research focuses on small to mid-sized companies with disruptive technologies that have the potential to drive significant market changes. MLV & Co.'s coverage universe includes the life sciences, oil & gas and metals & mining sectors. | Finance |
- Stock Market
- Insiders
- Miranda Toledano
- Experience
